Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

WOMENVENTURE

UEI: NJE5B1U82XP8CAGE: 37MC4

WOMENVENTURE is a federal contractor, registered under UEI NJE5B1U82XP8 and CAGE code 37MC4. It has been awarded $11,976,660 in federal contracts. Primary work spans Unknown NAICS and Other NAICS codes (1 codes, <0.5% each). Top awarding agencies include Department Of The Treasury, Small Business Administration, and Department Of Housing And Urban Development.

Contact Information

Registration and classification details

Registration

UEI Code

NJE5B1U82XP8

CAGE Code

37MC4

Entity Structure

Corporate Entity (Tax Exempt)

Established

N/A

Business Classifications

Community Development CorporationNon-Profit Organization

NAICS Codes

611430Professional and Management Development Training(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

WOMENVENTURE operates as a small business entity based in Saint Paul, Minnesota, with a primary NAICS classification of 611430, which corresponds to other schools and instruction—typically encompassing specialized educational services, professional training, and workforce development programs. While...

WOMENVENTURE operates as a small business entity based in Saint Paul, Minnesota, with a primary NAICS classification of 611430, which corresponds to other schools and instruction—typically encompassing specialized educational services, professional training, and workforce development programs. While no award history is available to infer specific contract performance, the company’s NAICS code suggests a focus on delivering non-traditional educational content, curriculum design, and instructional support services, potentially tailored to government workforce upskilling, compliance training, or technical education initiatives. Their operational model likely emphasizes adult learning methodologies, competency-based instruction, and scalable training delivery platforms, with an emphasis on accessibility and outcomes-driven program design. No agency relationships can be confirmed due to the absence of contract data, and no certifications are listed, indicating the company may be positioned as a new or emerging player in the federal services market. Without recent awards or documented engagements, there is no evidence of direct experience with specific federal departments or mission-critical programs. The company’s industry focus centers on educational services under NAICS 611430, placing it within the broader federal training and human capital development sector. This vertical often supports agencies seeking to enhance employee proficiency in areas such as cybersecurity awareness, procurement compliance, or administrative operations through customized learning solutions. WOMENVENTURE’s positioning appears to be that of a niche provider in professional instruction, potentially serving as a subcontractor or vendor for larger education and training contracts. As an 8H-certified entity, WOMENVENTURE qualifies as a women-owned small business under the SBA’s 8(a) program, which may enhance its eligibility for set-aside opportunities. The company maintains a localized presence in Minnesota but has no publicly documented federal footprint beyond its entity classification. Its market positioning hinges on its capacity to deliver agile, high-quality instructional services aligned with federal workforce development priorities.

Key Performance Metrics

Awards Count

47

All time

Active

2

Currently performing

Completed

45

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
Export
- Unknown NAICS$12.0M100%
Others - Other NAICS codes (1 codes, <0.5% each)$3.0K0%
Awards by Agency Over Time
Awards by Place of Performance

Compete with WOMENVENTURE

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for WOMENVENTURE

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in WOMENVENTURE's top NAICS codes and agencies

NAICS: 541715
SBIR / STTR
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
Solicitation # PA-27-102
The NIH Small Business Technology Transfer (STTR) grant, solicitation PA-27-102, provides early-stage funding for U.S. small business concerns (SBCs) to conduct research and development of commercial products in formal collaboration with non-profit research institutions. The program is designed to enhance health and reduce illness through a phased approach: Phase I focuses on establishing technical merit and feasibility, while Phase II advances the research toward commercialization. Eligible applicants must be for-profit entities located in the U.S., owned more than 50 percent by U.S. citizens or permanent residents, and employ no more than 500 people. The program accepts Phase I, Phase II, Direct to Phase II, and Fast-Track applications, with the latter two being NIH-specific options to accelerate development. Funding limits vary by the awarding NIH Institute or Center, with Phase I budgets typically ranging from 400,000 to 700,000 dollars and Phase II budgets reaching up to 3,000,000 dollars. Applications are evaluated via a peer review system based on an overall impact score, considering commercial potential, technical feasibility, and the quality of the commercialization plan. While clinical trials are generally optional, they require a specific regulatory plan and adherence to strict safety and registration guidelines; notably, several institutes, including NIAID and NIAMS, do not accept clinical trials under this NOFO. Applicants must maintain active registrations in SAM, possess a Unique Entity Identifier, and comply with cybersecurity incident reporting requirements, including notifying HHS within 48 hours of a discovery.
Department of Health and Human Services

POSTED

5 months ago

DEADLINE

in 6 months
View Details
NAICS: 541715
SBIR / STTR
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Solicitation # PA-27-100
The NIH, CDC, and FDA Small Business Innovation Research (SBIR) Grant, solicitation PA-27-100, provides early-stage funding to United States small business concerns (SBCs) to conduct research and development for commercial products. The program is structured in phases, with Phase I focusing on establishing technical merit and feasibility, and Phase II advancing the project toward commercialization. Eligible applicants include for-profit U.S. businesses with no more than 500 employees. The funding opportunity accepts Phase I, Phase II, Direct to Phase II, and Fast-Track applications, with the latter two being specific to the NIH. Budget limits vary by participating institute, with Phase I awards typically ranging from 400,000 to 700,000 dollars and Phase II awards reaching up to 3,000,000 dollars. Applications are evaluated through a peer review system based on scientific and technical merit, significance, and the suitability of the environment for success. While clinical trials are generally optional, they are prohibited for specific components, including all FDA centers and several NIH institutes such as NIAMS and NIDCR. Recipients must adhere to strict compliance requirements, including maintaining active SAM registration, disclosing foreign relationships, and implementing cybersecurity incident reporting procedures that notify agencies within 48 hours of discovery. All applications must be submitted electronically, with a final expiration date of April 06, 2027.
Department of Health and Human Services

POSTED

5 months ago

DEADLINE

in 6 months
View Details
NAICS: 541715
SBIR / STTR
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
Solicitation # PAR-27-098
The SBIR/STTR Commercialization Readiness Pilot (CRP) Program, solicitation PAR-27-098, is a funding opportunity provided by the National Institutes of Health (NIH) to help U.S.-based small business concerns transition technology from late-stage research and development to full commercialization. This program is specifically available to recipients of prior or active NIH SBIR or STTR Phase II or Phase IIB Strategic Breakthrough awards. The CRP supports activities that bridge the gap to market, including technical assistance for regulatory and intellectual property strategies, manufacturing scale-up, independent replication of key studies, and clinical trials. While significant outsourcing to contract research organizations is permitted, the small business must maintain a substantial role in project oversight and management. Eligible applicants must be for-profit organizations with no more than 500 employees and maintain active registrations in the System for Award Management and the SBA Company Registry. Project periods are limited to a maximum of three years, with budget ceilings varying by participating Institute or Center, ranging from 500,000 dollars to 2 million dollars, or following SBA guidelines for certain institutes. Applications are evaluated via NIH peer review based on scientific and technical merit, commercial potential, and relevance to program priorities. Key submission requirements include a detailed regulatory plan and a CRP progress report, while costs for patent or FDA filing fees and separate Technical and Business Assistance funding are strictly prohibited.
Department of Health and Human Services

POSTED

5 months ago

DEADLINE

in 6 months
View Details